Online Prescriptions

Online Prescriptions - Click Here
HomeAlpha IndexCategories

Bookmark and Share

Prescriptions : A

Prescriptions : B

Prescriptions : C

Prescriptions : D

Prescriptions : E

Prescriptions : F

Prescriptions : G

Prescriptions : H

Prescriptions : I

Prescriptions : J

Prescriptions : K

Prescriptions : L

Prescriptions : M

Prescriptions : N

Prescriptions : O

Prescriptions : P

Prescriptions : Q

Prescriptions : R

Prescriptions : S

Prescriptions : T

Prescriptions : U

Prescriptions : V

Prescriptions : W

Prescriptions : X

Prescriptions : Y

Prescriptions : Z

Prescriptions : 0-9

Home

Product Index

Category List

Catapres TTS 3 Generic Clonidine

Home » Prescription Drugs 4 » Catapres TTS 3 Generic Clonidine

Indications:CATAPRES-TTS is indicated for the treatment of mild to moderate hypertension. It can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.Dosage and Administration:CATAPRES-TTS dosage should be titrated according to individual patient's therapeutic requirements. Commence with one CATAPRES-TTS-1 applied weekly to a freshly cleaned hairless area of the upper outer arm or chest. A new site should be used each week when applying new patches. If after two to four weeks the desired reduction in blood pressure is not achieved increase the weekly dosage by changing to CATAPRES-TTS-2. If this dosage is still not satisfactory after 2-4 weeks therapy then increase the weekly dosage by changing to CATAPRES-TTS-3.Most patients with mild to moderate hypertension will be controlled on one CATAPRES-TTS-3 or less. In more resistant cases where blood pressure is not satisfactorily controlled on one CATAPRES-TTS-3 it is recommended that a diuretic and/or other antihypertensive agents be added to enhance the hypotensive effect. In this way the dose of each individual drug may be reduced and side effects minimised. Higher doses of up to two CATAPRES-TTS-3 a week have been utilised.When substituting CATAPRES-TTS in patients on prior oral antihypertensive therapy including oral CATAPRES physicians should be aware that the antihypertensive effect of CATAPRES-TTS might not commence until 2-3 days after initial application. Therefore gradual reduction of prior drug dosage over 5-6 days is advised.Instructions on correct application of CATAPRES-TTS are provided on a separate patient leaflet.

Buy Catapres TTS 3 Generic Clonidine and other Prescription Drugs 4 products online at Medstore.

5464
Buy Online at Medstore - Click Here!

About Catapres TTS 3 Generic Clonidine:

Product Type: Prescription Drugs 4

Catapres TTS-3 ( Generic Clonidine )

Catapres TTS-3 (Generic Clonidine)

Generic Clonidine

7.5mg/10.5cm 4 Pads Generic Clonidine Catapres TTS-3

View more Prescription Drugs 4

Previous Product  Next Product

Online Prescriptions.
 
Industry News : Marquette General Health System joins Premier healthcare alliance. Marquette General Health System of Marquette, Mich., has joined the Premier healthcare alliance, consisting of more than 2,500 hospitals and 76,000 other healthcare sites, to improve care delivery. “We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier.” As a Premier owner, Marquette leverages a national purchasing network delivering industry-leading contract pricing. The not-for-profit health system formerly utilized MedAssets as its national purchasing organization. Marquette also collaborates and compares performance with other members of the alliance to improve care efficiency while safely reducing waste and costs using the nation's largest clinical, financial and operational database. "Premier's business model is unique in that it is completely owned by its members and thus accountable to and fully aligned with their goals," said Gary Muller, president & CEO at Marquette. "We believe this new partnership will help improve the value of the health services Marquette provides to our community and look forward to furthering our work with Premier." The health system participates in two Premier collaboratives for additional performance improvement opportunities. As a new member of Premier's ASCEND® (Accelerated Supply Chain Endeavor) program, Marquette aggregates, monitors and analyzes supply chain data to identify improvement opportunities. This includes simplified and consistent purchasing processes, appropriate clinical utilization and specially negotiated contracts. Members of ASCEND have saved $56 million over two years, without sacrificing the quality of care. To support its purchasing decisions, the health system uses Premier supply chain tools like SpendAdvisor® MySpend™, to easily examine spend data.
 
MACLAR Klacid 
Macrobid (Nitrofurantoin) 
Macrodantin (Nitrofurantoin Macrocystals) 
MADOPAR Prolopa 
Malirid Generic Primaquine 
Marvelon Desogestrel Ethinyl Oestradiol 
Maxalt (Rizatriptan) 
Maximune Invirase 
Maxolon Clopra 
Maxolon (Metoclopramide) 
MEBEX Vermox 
Medrol Deltastab 
MEFTAL Ponstel 
Melalite Forte Cream Aclaro 
Melanocyl Uvadex 
MELOSET MEL 
Memantine NAMENDA 
M Enalapril Generic Renitec 
Meprate Modus 
MESACOL Asacol 
Metaspray Nasonex 
Metformin Generic Glucophage 
Methotrexate 
Methycobal Generic Mecobalamin 
Metocard XL Toprol XR 
METOLAR Betaloc 
METOLAR H Selopres 
Metpamid Reglan